Executive Trades

SEM Insider Sells 1,330 Shares on May 04, 2026

May 6, 2026
6 min read

Key Points

Robert Breighner, SEM Senior Vice President, sold 1,330 shares at $16.44 on May 04, 2026.

The insider retained 34,696 shares after the disposition, indicating continued confidence.

Form 4 SEC filing disclosed the transaction within two business days as required.

Single insider sales require careful interpretation and should be monitored for broader patterns.

Be the first to rate this article

Insider trading activity often signals confidence or concern about a company’s future. When executives buy, markets pay attention. When they sell, investors wonder why. Today we examine a significant insider transaction at SEM (Select Medical Holdings Corporation), where a senior vice president disposed of over 1,300 shares. This insider transaction occurred on May 04, 2026, and was filed with the SEC on May 05, 2026. Understanding what this sale means requires looking at the details, the insider’s role, and the broader context of insider trading activity at this healthcare company.

The Insider Transaction Details

Robert G. Breighner Jr., Senior Vice President at Select Medical Holdings, disposed of 1,330 shares of common stock on May 04, 2026. The transaction was reported via a Form 4 filing with the SEC on May 05, 2026.

Share Disposition and Pricing

Breighner sold his shares at $16.44 per share, generating approximately $21,865.20 in total proceeds. This represents a straightforward disposition of company stock. After the sale, Breighner retained 34,696 shares of Select Medical Holdings common stock, showing he maintains significant ownership in the company despite the sale.

Form Type and Transaction Code

The SEC filing shows this as a Form 4 transaction with code F-InKind, which indicates a disposition or sale of securities. Form 4 filings are required within two business days of any transaction by company officers, directors, or significant shareholders. This transparency requirement helps investors track insider activity and potential signals about company health.

Understanding the Insider’s Role and Holdings

Robert Breighner holds the position of Senior Vice President at Select Medical Holdings, placing him in a key leadership role. His continued substantial shareholding after this transaction reveals important context about insider confidence.

Leadership Position and Responsibility

As a Senior Vice President, Breighner has access to material non-public information about the company’s operations, financial performance, and strategic direction. His role gives him insight into Select Medical’s business that most investors lack. This makes his trading activity particularly noteworthy to market observers and analysts tracking insider sentiment.

Remaining Ownership Stake

After disposing of 1,330 shares, Breighner still owns 34,696 shares of common stock. This substantial remaining position suggests he has not lost confidence in Select Medical Holdings. Insiders who completely exit their positions often signal serious concerns. Partial sales like this one can reflect portfolio rebalancing, tax planning, or personal financial needs rather than negative company outlook.

What This Insider Sale Means for Investors

A single insider transaction rarely tells the complete story about a company’s prospects. However, it does provide one data point in the broader picture of insider sentiment at Select Medical Holdings.

Interpreting Single Insider Dispositions

One senior executive selling shares does not automatically indicate trouble ahead. Insiders sell for many reasons: diversifying investments, funding personal expenses, exercising stock options, or managing tax obligations. The key is whether this represents an isolated event or part of a larger pattern of insider selling. Meyka AI rates SEM a grade of B, factoring in sector performance, financial metrics, and analyst consensus to help investors evaluate the company holistically.

Investors should track whether additional insiders at Select Medical Holdings buy or sell in coming weeks and months. Coordinated selling by multiple executives would signal greater concern than a single officer’s transaction. Conversely, if other insiders continue buying, it suggests confidence despite this one sale. The May 04, 2026 transaction provides a baseline for comparing future insider activity at this healthcare company.

Select Medical Holdings Context and Market Position

Select Medical Holdings Corporation operates in the healthcare services sector, providing specialized rehabilitation and long-term acute care services. Understanding the company’s market position helps contextualize insider trading activity.

Company Scale and Market Cap

With a market capitalization of approximately $2,039,480,944, Select Medical Holdings is a mid-cap healthcare company. This size places it in a segment where insider transactions can move stock prices and attract investor attention. The company’s scale means insider trades are significant enough to warrant SEC disclosure and investor scrutiny.

Healthcare Sector Dynamics

The healthcare services industry faces ongoing pressures from regulatory changes, reimbursement rates, and labor costs. Insiders at companies like Select Medical Holdings navigate these challenges daily. When executives make trading decisions, they do so with full knowledge of these sector-specific headwinds and opportunities. This context matters when evaluating what Breighner’s May 04 sale might signal about management’s outlook.

Final Thoughts

Robert Breighner’s sale of 1,330 shares at $16.44 on May 04, 2026, represents a routine insider transaction at Select Medical Holdings. The Senior Vice President’s decision to dispose of shares while retaining over 34,000 shares suggests portfolio management rather than loss of confidence. Single insider transactions require careful interpretation, as executives sell for many legitimate reasons unrelated to company outlook. Investors should monitor whether this sale is followed by additional insider activity at SEM. Meyka AI’s B grade for Select Medical Holdings reflects a balanced assessment of the company’s fundamentals and market position, independent of any single insider trade.

FAQs

What does Form 4 mean in insider trading?

Form 4 is an SEC filing required within two business days when company officers, directors, or major shareholders buy or sell stock. It discloses transaction details including shares, price, and timing. Form 4 filings provide transparency about insider trading activity.

Why did Robert Breighner sell 1,330 shares?

The SEC filing doesn’t specify the reason. Insiders sell for many reasons: portfolio rebalancing, personal expenses, tax planning, or option exercises. A single sale doesn’t necessarily indicate negative company outlook, especially when the insider retains significant holdings.

What is F-InKind transaction code?

F-InKind indicates a disposition or sale of securities. It’s one of several transaction codes the SEC uses to categorize insider trades. This code specifically marks when an insider sells or disposes of company stock.

Does one insider sale mean the stock will drop?

No. Single insider transactions rarely predict stock price movements. Many factors influence stock prices. Investors should track patterns of insider activity over time rather than reacting to isolated trades by one executive.

How much stock does Breighner still own?

After the May 04 sale, Robert Breighner retained 34,696 shares of Select Medical Holdings common stock. This substantial remaining position suggests he maintains confidence in the company despite selling 1,330 shares.

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes. Insider trading data is sourced from public SEC filings. This is not financial advice. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask Meyka Analyst about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)